Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications [1]. Group 1: Legal Action Details - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, may be eligible for compensation without upfront costs through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - The lawsuit alleges that Marex made materially false statements and failed to disclose critical information regarding its financial practices, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

GS China Strategy Views Your "5-Year Plan" in a Slow(er) Bull Market Asia Strategy Views November 2025 Kinger Lau, CFA Goldman Sachs (Asia) L.L.C. 852-2978-1224 Kinger.Lau@gs.com Si Fu, PhD Goldman Sachs (Asia) L.L.C. 852-2978-0200 Si.Fu@gs.com Kevin Wang, CFA Goldman Sachs (Asia) L.L.C. 852-2978-2446 Kevin.Wang@gs.com MSCI China has bounced 80% from the cycle lows in late 2022, but disrupted by 4 major drawdowns. We now call for a more sustained uptrend, forecasting key indexes to rise 30-40% and reach all ...

Core Points - Rosen Law Firm is reminding investors who purchased securities of Marex Group plc between May 16, 2024, and August 5, 2025, about the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Case Details - The lawsuit alleges that during the Class Period, Marex made materially false and misleading statements and failed to disclose critical information, including: 1. Marex sold over-the-counter financial instruments to itself 2. There were inconsistencies in financial statements between subsidiaries and related parties 3. Marex's financial statements could not be relied upon 4. Positive statements about Marex's business were materially misleading [4] Legal Representation - Investors are encouraged to select qualified counsel with a successful track record in securities class actions, as many firms may not have the necessary experience or resources [3] - Rosen Law Firm has achieved significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [3]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by December 8, 2025 [3][6]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false and misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [6]. - A report from NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions, including a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [7]. - Following the release of the report, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 on heavy trading volume [9]. Group 2: Legal Actions and Investor Options - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995, indicating its capability in handling such cases [5]. - Any member of the putative class can move the court to serve as lead plaintiff or choose to remain an absent class member, with no impact on their ability to share in any recovery [10].

Core Insights - Ameriprise Financial, Inc. has received a consensus rating of "Hold" from eleven research firms, with varying recommendations including two sell, five hold, three buy, and one strong buy [2] - The average twelve-month price target among analysts is $533.22 [2] Analyst Ratings - Morgan Stanley reduced its price target from $530.00 to $484.00 and assigned an "underweight" rating [3] - Weiss Ratings maintained a "buy (b)" rating [3] - Keefe, Bruyette & Woods lowered their target price from $550.00 to $530.00 with a "market perform" rating [3] - Royal Bank of Canada cut its price target from $601.00 to $550.00 while maintaining an "outperform" rating [3] - BMO Capital Markets initiated coverage with a "market perform" rating and a price target of $525.00 [3] Stock Performance - Ameriprise Financial stock opened at $447.55, with a 52-week low of $396.14 and a high of $582.05 [4] - The stock has a market capitalization of $41.58 billion, a price-to-earnings ratio of 13.92, and a PEG ratio of 1.07 [4] Earnings Results - For the quarter ending October 30th, Ameriprise reported earnings per share (EPS) of $9.92, exceeding the consensus estimate of $9.76 by $0.16 [5] - The company achieved a return on equity of 65.90% and a net margin of 18.30% [5] - Revenue for the quarter was $4.73 billion, surpassing analyst estimates of $4.51 billion, and reflecting a 9.0% increase compared to the same quarter last year [5] - Analysts project an EPS of 38.64 for the current fiscal year [5] Dividend Announcement - Ameriprise Financial declared a quarterly dividend of $1.60, payable on November 24th, with an annualized dividend of $6.40 and a yield of 1.4% [6] - The company's payout ratio is currently 17.55% [6] Insider Transactions - EVP Heather J. Melloh sold 1,500 shares at an average price of $512.34, totaling $768,510, which represents a 36.93% decrease in her position [7] - Corporate insiders own 0.73% of the company's stock [7] Institutional Investor Activity - Trust Co. of Vermont increased its stake by 0.6%, now owning 3,031 shares valued at $1.618 million [8] - Plancorp LLC raised its position by 4.8%, owning 441 shares worth $213,000 [8] - Old Port Advisors and Linden Thomas Advisory Services LLC also increased their holdings by 1.5% and 0.5%, respectively [9] - Institutional investors collectively own 83.95% of the company's stock [9] Company Overview - Ameriprise Financial provides various financial products and services to individual and institutional clients, operating through four segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other [10]

Core Points - Rosen Law Firm is encouraging investors of Marex Group plc who incurred losses exceeding $100,000 during the Class Period from May 16, 2024, to August 5, 2025, to secure legal counsel before the December 8, 2025, deadline for lead plaintiff applications [1][5]. Group 1: Legal Action Details - Investors who purchased Marex securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements, leading to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in securing significant settlements for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and recovering over $438 million for investors in 2019 [4].

Core Points - Rosen Law Firm is reminding investors who purchased Marex Group plc securities between May 16, 2024, and August 5, 2025, of the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Marex securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by December 8, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that during the Class Period, Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements [5]. - It is claimed that Marex's financial statements could not be relied upon, and positive statements about the company's business were materially misleading [5].

Core Insights - Two-thirds of Americans are using generative AI for financial advice, with a significant portion using it frequently and feeling comfortable asking questions they might avoid with traditional financial advisors [1][2]. Usage and Perception of GenAI - GenAI is viewed as a powerful tool for personalized financial learning and management, according to Courtney Alev from Intuit Credit Karma [2]. - Users of GenAI report positive outcomes, with 80% stating their finances improved and 81% feeling more confident in managing their money [4]. Trustworthiness and Effectiveness - Economist Andrew Lo indicates that large language models like ChatGPT can provide reasonably accurate personal finance advice, although they may not fully pass as reliable advisors [3][4]. - Among those who have used AI for financial assistance, 79% found the information accurate and 71% deemed it helpful [5]. Common Financial Topics - The most common topics people inquire about when using GenAI include: - Financial education and basic personal finance concepts (35%) - Financial goal setting and action plans (35%) - Budgeting and expense management (34%) - Optimizing savings (33%) - Investing in the stock market (32%) [6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit set for December 8, 2025 [3][8]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false and misleading statements, failing to disclose significant issues such as selling over-the-counter financial instruments to itself and inconsistencies in financial statements [6]. - A report by NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions, including a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [7]. - Following the release of the report, Marex's stock experienced a significant decline of 6.2%, closing at $35.31 [9]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased Marex securities between May 16, 2024, and August 5, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [2]. - The role of lead plaintiff in the class action lawsuit is designated for the investor with the largest financial interest, who will oversee the litigation on behalf of the class [10]. - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding Marex's conduct [11].

Core Insights - As the year-end approaches, many Americans are focusing on holiday activities, but it is also a critical time for financial deadlines that could impact tax liabilities and savings [1][2] Group 1: Financial Moves Before Year-End - The deadline for contributions to 401(k) retirement plans is December 31, with opportunities for catch-up contributions for those over 50 [3] - A significant number of employees are not maximizing their employer's 401(k) match, with 24% saving less than the match cap from 2013 to 2022 [4][5] - Tax loss harvesting is an underutilized strategy that allows investors to convert capital losses into tax savings, with the ability to offset capital gains and reduce taxable income by up to $3,000 [6][7]